These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12473239)

  • 1. Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cell.
    Kissler S; Anderton SM; Wraith DC
    J Autoimmun; 2002 Dec; 19(4):183-93. PubMed ID: 12473239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell recognition of rat myelin basic protein as a TCR antagonist inhibits reciprocal activation of antigen-presenting cells and engenders resistance to experimental autoimmune encephalomyelitis.
    Walker MR; Mannie MD
    Eur J Immunol; 2001 Jun; 31(6):1894-9. PubMed ID: 11433386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking.
    Aharoni R; Teitelbaum D; Arnon R; Sela M
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):634-9. PubMed ID: 9892685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation.
    Matyszak MK; Denis-Donini S; Citterio S; Longhi R; Granucci F; Ricciardi-Castagnoli P
    Eur J Immunol; 1999 Oct; 29(10):3063-76. PubMed ID: 10540317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous myelin basic protein is presented in the periphery by both dendritic cells and resting B cells with different functional consequences.
    Seamons A; Perchellet A; Goverman J
    J Immunol; 2006 Aug; 177(4):2097-106. PubMed ID: 16887968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine specificity of the myelin-reactive T cell repertoire: implications for TCR antagonism in autoimmunity.
    Anderton SM; Manickasingham SP; Burkhart C; Luckcuck TA; Holland SJ; Lamont AG; Wraith DC
    J Immunol; 1998 Oct; 161(7):3357-64. PubMed ID: 9759852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T lymphocyte lines and clones selected against synthetic myelin basic protein 82-102 peptide from Japanese multiple sclerosis patients.
    Inobe J; Yamamura T; Kunishita T; Tabira T
    J Neuroimmunol; 1993 Jul; 46(1-2):83-90. PubMed ID: 7689597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of T-cell receptor binding by bivalent HLA-DR. Peptide complexes that activate antigen-specific human T-cells.
    Appel H; Gauthier L; Pyrdol J; Wucherpfennig KW
    J Biol Chem; 2000 Jan; 275(1):312-21. PubMed ID: 10617620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition.
    Patel DM; Arnold PY; White GA; Nardella JP; Mannie MD
    J Immunol; 1999 Nov; 163(10):5201-10. PubMed ID: 10553040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fine specificity of myelin basic protein reactive T-cells: implications for T-cell receptor antagonism.
    Anderton SM; Manickasingham SP; Wraith DC
    Biochem Soc Trans; 1997 May; 25(2):659-61. PubMed ID: 9191175
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergy between encephalitogenic T cells and myelin basic protein-specific antibodies in the induction of experimental autoimmune encephalomyelitis.
    Myers KJ; Sprent J; Dougherty JP; Ron Y
    J Neuroimmunol; 1992 Nov; 41(1):1-8. PubMed ID: 1281165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of antigen-presenting cells in the polarized development of helper T cell subsets: evidence for differential cytokine production by Th0 cells in response to antigen presentation by B cells and macrophages.
    Duncan DD; Swain SL
    Eur J Immunol; 1994 Oct; 24(10):2506-14. PubMed ID: 7925578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes.
    Wucherpfennig KW; Hafler DA; Strominger JL
    Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8896-900. PubMed ID: 7568039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendritic cells purified from myeloma are primed with tumor-specific antigen (idiotype) and activate CD4+ T cells.
    Dembic Z; Schenck K; Bogen B
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2697-702. PubMed ID: 10706628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A major influence of the T cell receptor repertoire as compared to antigen processing-presentation in the selection of myelin basic protein epitopes in multiple sclerosis.
    Ristori G; Montesperelli C; Uccelli A; Giunti D; Buttinelli C; Bomprezzi R; Mancardi GL; Salvetti M
    J Neuroimmunol; 1999 May; 96(2):241-4. PubMed ID: 10337923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonactivated astrocytes downregulate T cell receptor expression and reduce antigen-specific proliferation and cytokine production of myelin basic protein (MBP)-reactive T cells.
    Sun D; Coleclough C; Whitaker JN
    J Neuroimmunol; 1997 Sep; 78(1-2):69-78. PubMed ID: 9307229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease.
    Kumar V; Sercarz EE
    J Exp Med; 1993 Sep; 178(3):909-16. PubMed ID: 7688792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
    Kumar V; Stellrecht K; Sercarz E
    J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cells with two functional antigen-specific receptors.
    Hardardottir F; Baron JL; Janeway CA
    Proc Natl Acad Sci U S A; 1995 Jan; 92(2):354-8. PubMed ID: 7530361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
    Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
    J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.